Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Enrolling by invitation × UNKNOWN × Clear all

Phase

Status

Unknown 155 Completed 56 Terminated 6 Recruiting 5 Withdrawn 2 Enrolling by invitation 2 Suspended 1 Not yet recruiting 1 Available 1

Sponsor Class

OTHER 503 INDUSTRY 69 OTHER_GOV 27 NIH 16 NETWORK 4 UNKNOWN 2

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Thoracic 1 Lymphoid 1

Conditions

Lymphoma, Large B-Cell, Diffuse 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

aumolertinib 1 Pemetrexed 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04762459 2022-02-24

APEX

ChineseAMS

Phase 3 Enrolling by invitation

Carcinoma, Non-Small-Cell Lung

NCT04491721 2020-07-29

Follow-up the OS and PFS of Rituximab Biosimilar HLX01 and MabThera, in Untreated Subjects With CD20+ DLBCL

ChineseAMS

Enrolling by invitation

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡